Inventor · disambiguated record
Mitsuhiro Matono
Also filed as: MATONO MITSUHIRO
3 granted patents·5 pending applications·0 citations·filing 2010–2022
41Inventor score
Files withINTERCEPT PHARMACEUTICALS INC2MATONO MITSUHIRO2NIHON MEDIPHYSICS CO LTD2SUMITOMO DAINIPPON PHARMA CO LTD2
Top patents by PatentIndex Score
8 records- 0157US11369701B2Ri-labeled humanized antibodyNIHON MEDIPHYSICS CO LTD·Filed 2021·Granted Jun 28, 2022·0 cites·18 claims
- 0256US2019290579A1Orally disintegrating tablet having inner coreMATONO MITSUHIRO·Filed 2018·Application pending·0 cites
- 0354US2024189461A1Humanised antibodies labelled with radionuclides that emit beta-raysNIHON MEDIPHYSICS CO LTD·Filed 2022·Application pending·0 cites
- 0449US2021338170A1Method, device, and program for assessing relevance of respective preventive interventional actions to health in health domain of interestSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2019·Application pending·0 cites
- 0549US2022144927A1Humanized antibody and method for using the sameSUMITOMO DAINIPPON PHARMA CO LTD·Filed 2020·Application pending·0 cites
- 0646US2011305758A1Orally disintegrating tablet having inner coreMATONO MITSUHIRO·Filed 2010·Application pending·0 cites
- 0738US11413295B2Oral preparation of obeticholic acidINTERCEPT PHARMACEUTICALS INC·Filed 2017·Granted Aug 16, 2022·0 cites·14 claims
- 0836US11331273B2Film-coated tablet having high chemical stability of active ingredientINTERCEPT PHARMACEUTICALS INC·Filed 2017·Granted May 17, 2022·0 cites·13 claims
Join the waitlist — get patent alerts
Get an alert when Mitsuhiro Matono files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →